skip to main content

brainstorm askiatroX medicines

simulations beta

loading page…

learn & practise

exams international doctors free questions Socratic Tutor rounds stat clinical connections academy journal tool guides

clinical reference

askiatroX knowledge centre medicines UK / NICE guidance international guidance calculators q&a library

trust & support

how it works methodology account & support frequently asked questions about us clinical safety consultancy

legal

mobile app · scan to download

Medicines fruquintinibQuestion & answer

fruquintinib · Medicine question

Which VEGF receptor subtypes does fruquintinib inhibit?

iatroX medicinesPublished 8 November 2026

The answer

Answer

Fruquintinib inhibits vascular endothelial growth factor receptor subtypes VEGFR-1, VEGFR-2 and VEGFR-3.

Sources for this answer

FRUZAQLA 1 mg hard capsulesTakeda UK Ltd · emc · SmPC §5.1 Pharmacodynamic properties · Version 4Document updated 15 October 2026

Sources checked 8 November 2026

Explore this learning need in CPDTake this topic to CPD, then choose your learning context and available question library.

The full medicine guide

fruquintinib

More questions about fruquintinib

Does rabeprazole meaningfully affect exposure to fruquintinib?How common is hypothyroidism with fruquintinib in patients with metastatic colorectal cancer?How long should breastfeeding be avoided during and after fruquintinib treatment?How much tartrazine and sunset yellow FCF does each Fruzaqla 1 mg fruquintinib capsule contain?What are the allergy-related contraindications to fruquintinib?What are the risks of using fruquintinib during pregnancy?

Read the wider context, including uses, precautions and the sources behind this medicine guide.

Read the fruquintinib guide

More clinical questions?

Explore the tools and reference material available on iatroX.

Explore askiatroX